Investigational Compound Retatrutide (also called GLP-3 or "reta") is in Phase 3 clinical trials
5 Pharmacological effects of GIP, GLP-1 and their mimetics The pharmacological benefits of GIP, GLP-1, and their synthetic mimetics arise from their pleiotropic effects, encompassing at least five key functions: bolstering insulin secretion and survival of pancreatic -cells and modulating glucagon release by the pancreatic -cells in response to glycemic levels, acting on the satiety center in brain, slowing gastric emptying, regulating lipid and glucose metabolism through effects on adipose tissue and liver, and reducing systemic blood pressure
A., Toth, F
Jillian Michaels: Professionally, it's enabled me to reach millions of people around the world, to help improve the quality of their health, and their happiness
With their proven effectiveness and safety, GLP-1 receptor agonists (GLP-1 RAs) have become the leading weight-loss medications worldwide, prompting the pharmaceutical industry to ramp up research and development efforts in this area
Technological advancements in delivery systems, including prefilled pens and auto-injectors, have significantly improved patient convenience and treatment adherence
